102 related articles for article (PubMed ID: 6417154)
1. Pharmacological activation of gamma-aminobutyric acid-system blunts prolactin response to mechanical breast stimulation in puerperal women.
Melis GB; Fruzzetti F; Paoletti AM; Mais V; Kemeny A; Strigini F; Boldrini A; Fioretti P
J Clin Endocrinol Metab; 1984 Jan; 58(1):201-5. PubMed ID: 6417154
[TBL] [Abstract][Full Text] [Related]
2. The effects of the gabaergic drug, sodium valproate, on prolactin secretion in normal and hyperprolactinemic subjects.
Melis GB; Paoletti AM; Mais V; Mastrapasqua NM; Strigini F; Fruzzetti F; Guarnieri G; Gambacciani M; Fioretti P
J Clin Endocrinol Metab; 1982 Mar; 54(3):485-9. PubMed ID: 6799535
[TBL] [Abstract][Full Text] [Related]
3. Effects of the GABAergic drug, sodium valproate, on the prolactin release evoked by pharmacological stimuli in normal women.
Melis GB; Fruzzetti F; Paoletti AM; Mais V; Beneventi F; Trimarchi G; Fioretti P
Clin Endocrinol (Oxf); 1984 Mar; 20(3):245-52. PubMed ID: 6426828
[TBL] [Abstract][Full Text] [Related]
4. Effects of naloxone infusion on basal and breast-stimulation-induced prolactin secretion in puerperal women.
Lodico G; Stoppelli I; Delitala G; Maioli M
Fertil Steril; 1983 Nov; 40(5):600-3. PubMed ID: 6685061
[TBL] [Abstract][Full Text] [Related]
5. [Plasma prolactin response to suckling stimulation in puerperal women].
Masaoka K; Niibe T; Kumasaka T; Saito M
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jan; 36(1):37-43. PubMed ID: 6699448
[TBL] [Abstract][Full Text] [Related]
6. Role of opiates in the physiological control of prolactin in man.
Lo Dico G; Riggio V; Cossu A; Buscarinu G; Delitala G; Stoppelli I
Acta Eur Fertil; 1983; 14(6):409-14. PubMed ID: 6326452
[TBL] [Abstract][Full Text] [Related]
7. Role of central nervous system-derived or circulating gamma-aminobutyric acid on prolactin secretion in the rat.
Apud JA; Racagni G; Iuliano E; Cocchi D; Casanueva F; Müller EE
Endocrinology; 1981 Apr; 108(4):1505-10. PubMed ID: 7472280
[TBL] [Abstract][Full Text] [Related]
8. Opioid modulation of the gamma-aminobutyric acid-controlled inhibition of exercise-stimulated growth hormone and prolactin secretion in normal men.
Coiro V; Volpi R; Maffei ML; Caiazza A; Caffarri G; Capretti L; Colla R; Chiodera P
Eur J Endocrinol; 1994 Jul; 131(1):50-5. PubMed ID: 8038904
[TBL] [Abstract][Full Text] [Related]
9. Different sensitivity to sodium valproate in healthy, non-tumoral and tumoral hyperprolactinemic subjects.
Sarnacchiaro F; Colao A; Merola B; Di Sarno A; Landi ML; Di Somma C; Ferone D; Tolino A; Lombardi G
J Endocrinol Invest; 1997 Oct; 20(9):513-8. PubMed ID: 9413804
[TBL] [Abstract][Full Text] [Related]
10. Dose-related prolactin inhibitory effect of the new long-acting dopamine receptor agonist cabergoline in normal cycling, puerperal, and hyperprolactinemic women.
Melis GB; Gambacciani M; Paoletti AM; Beneventi F; Mais V; Baroldi P; Fioretti P
J Clin Endocrinol Metab; 1987 Sep; 65(3):541-5. PubMed ID: 3624413
[TBL] [Abstract][Full Text] [Related]
11. Circadian variation of basal plasma prolactin, prolactin response to suckling, and length of amenorrhea in nursing women.
Díaz S; Serón-Ferré M; Cárdenas H; Schiappacasse V; Brandeis A; Croxatto HB
J Clin Endocrinol Metab; 1989 May; 68(5):946-55. PubMed ID: 2715293
[TBL] [Abstract][Full Text] [Related]
12. Changes in the effect of gamma-aminobutyric acid on prolactin secretion during sexual maturation in female rats.
Moguilevsky JA; Carbone S; Szwarcfarb B
Endocrinology; 1992 Jul; 131(1):458-62. PubMed ID: 1319326
[TBL] [Abstract][Full Text] [Related]
13. [Prolactin secretion during normal pregnancy and puerperium, particularly with regard to nursing (author's transl)].
Wada Y
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jul; 32(7):891-8. PubMed ID: 6787151
[TBL] [Abstract][Full Text] [Related]
14. Failure of the GABAergic drug, sodium valproate, to reduce basal plasma prolactin secretion in chronic schizophrenia.
Monteleone P; Zontini G; Steardo L
Psychoneuroendocrinology; 1985; 10(4):475-80. PubMed ID: 3003777
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological activation of the GABAergic system does not affect GH and PRL release in acromegaly.
Orio F; Iovino M; Monteleone P; Agrusta M; Steardo L; Lombardi G
Horm Metab Res; 1988 Nov; 20(11):701-4. PubMed ID: 2850985
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of lactation and inhibition of prolactin release after mechanical breast stimulation in puerperal women given tamoxifen or placebo.
Masala A; Delitala G; Lo Dico G; Stoppelli I; Alagna S; Devilla L
Br J Obstet Gynaecol; 1978 Feb; 85(2):134-7. PubMed ID: 626722
[TBL] [Abstract][Full Text] [Related]
17. Prevention of puerperal lactation by a single oral administration of the new prolactin-inhibiting drug, cabergoline.
Melis GB; Mais V; Paoletti AM; Beneventi F; Gambacciani M; Fioretti P
Obstet Gynecol; 1988 Mar; 71(3 Pt 1):311-4. PubMed ID: 3279351
[TBL] [Abstract][Full Text] [Related]
18. Differential release of prolactin variants in postpartum and early follicular phase women.
Liu JH; Lee DW; Markoff E
J Clin Endocrinol Metab; 1990 Sep; 71(3):605-10. PubMed ID: 2118537
[TBL] [Abstract][Full Text] [Related]
19. Action of metergoline in suppressing prolactin release induced by mechanical breast emptying.
Delitala G; Lodico G; Masala A; Alagna S; Devilla L
J Clin Endocrinol Metab; 1977 Apr; 44(4):763-5. PubMed ID: 849985
[TBL] [Abstract][Full Text] [Related]
20. A prospective longitudinal study of the release of oxytocin and prolactin in response to infant suckling in long term lactation.
Johnston JM; Amico JA
J Clin Endocrinol Metab; 1986 Apr; 62(4):653-7. PubMed ID: 3949949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
